ADC Therapeutics Ltd (ADCT) has issued an announcement.
ADC Therapeutics SA’s Board of Directors has recently endorsed a new cash-based incentive, the Annual Bonus Plan, designed to financially recognize the hard work and success-driven contributions of its employees and executive officers. Starting with the 2024 bonus period, the plan will allocate bonuses in line with the achievement of the company’s strategic goals, incentivizing further growth and performance.
For detailed information about ADCT stock, go to TipRanks’ Stock Analysis page.